Evaluation of adverse effects in intracarotid propofol injection for Wada test.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16148262.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors evaluated adverse effects of intracarotid propofol injection during a Wada test and their risk factors in 58 patients. Nineteen patients had an adverse effect, mostly in patients receiving more than 10 mg. For patients older than age 55 years or those requiring an injection dose greater than 20 mg to produce hemiplegia, propofol should be injected slowly and patients monitored for excitatory movements.
Medical subject headings
- Cerebral Cortex
- Postoperative Complications
- Preoperative Care
- Propofol